Skip to main content

Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Description

In this request, we examined utilization patterns of ten pediatric drug-device or biologic-device combinations: Admelog (insulin lispro), Humalog KwikPen and Humalog Junior KwikPen (insulin lispro), Beconase (beclomethasone), EpiPen and EpiPen Jr. (epinephrine), epinephrine instramuscular, Evzio (naloxone), fluticasone metered, Neulasta (pegfilgrastim), Humira (adalimumab), and Norditropin (somatropin).

The study period includes data from January 1, 2018 to March 31, 2019. We executed this request on Merative™ MarketScan® Research Databases on August 27, 2020.

Deliverables (1)
Sentinel Query Builder Report: Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2018 - March 31, 2019
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Merative™ MarketScan® Research Databases
Related Links
Sentinel Drug Analysis: Counts and Characteristics of Individuals 25 Years or Younger With Drug-Device or Biologic-Device Combination Use: A Descriptive Analysis
Drug-Device or Biologic-Device Combinations & Utilization